Logo image of CTRI

CENTURI HOLDINGS INC (CTRI) Stock Fundamental Analysis

USA - NYSE:CTRI - US1559231055 - Common Stock

20.66 USD
+0.33 (+1.62%)
Last: 10/9/2025, 3:14:09 PM
Fundamental Rating

3

CTRI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 53 industry peers in the Construction & Engineering industry. The financial health of CTRI is average, but there are quite some concerns on its profitability. CTRI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year CTRI was profitable.
In the past year CTRI had a positive cash flow from operations.
CTRI Yearly Net Income VS EBIT VS OCF VS FCFCTRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

CTRI's Return On Assets of -0.15% is on the low side compared to the rest of the industry. CTRI is outperformed by 67.92% of its industry peers.
CTRI has a Return On Equity of -0.57%. This is in the lower half of the industry: CTRI underperforms 67.92% of its industry peers.
CTRI has a Return On Invested Capital (4.34%) which is in line with its industry peers.
CTRI had an Average Return On Invested Capital over the past 3 years of 4.36%. This is significantly below the industry average of 16.96%.
Industry RankSector Rank
ROA -0.15%
ROE -0.57%
ROIC 4.34%
ROA(3y)-5.23%
ROA(5y)N/A
ROE(3y)-42.36%
ROE(5y)N/A
ROIC(3y)4.36%
ROIC(5y)N/A
CTRI Yearly ROA, ROE, ROICCTRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

The Operating Margin of CTRI (3.50%) is comparable to the rest of the industry.
CTRI's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 8.67%, CTRI is not doing good in the industry: 73.58% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CTRI has declined.
Industry RankSector Rank
OM 3.5%
PM (TTM) N/A
GM 8.67%
OM growth 3Y-6.01%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.56%
GM growth 5YN/A
CTRI Yearly Profit, Operating, Gross MarginsCTRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 -5

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CTRI is destroying value.
Compared to 1 year ago, CTRI has more shares outstanding
Compared to 1 year ago, CTRI has an improved debt to assets ratio.
CTRI Yearly Shares OutstandingCTRI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
CTRI Yearly Total Debt VS Total AssetsCTRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

CTRI has an Altman-Z score of 2.19. This is not the best score and indicates that CTRI is in the grey zone with still only limited risk for bankruptcy at the moment.
CTRI's Altman-Z score of 2.19 is in line compared to the rest of the industry. CTRI outperforms 41.51% of its industry peers.
The Debt to FCF ratio of CTRI is 7.09, which is on the high side as it means it would take CTRI, 7.09 years of fcf income to pay off all of its debts.
CTRI's Debt to FCF ratio of 7.09 is in line compared to the rest of the industry. CTRI outperforms 52.83% of its industry peers.
CTRI has a Debt/Equity ratio of 1.59. This is a high value indicating a heavy dependency on external financing.
CTRI's Debt to Equity ratio of 1.59 is on the low side compared to the rest of the industry. CTRI is outperformed by 71.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF 7.09
Altman-Z 2.19
ROIC/WACC0.37
WACC11.61%
CTRI Yearly LT Debt VS Equity VS FCFCTRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.72 indicates that CTRI should not have too much problems paying its short term obligations.
With an excellent Current ratio value of 1.72, CTRI belongs to the best of the industry, outperforming 81.13% of the companies in the same industry.
CTRI has a Quick Ratio of 1.72. This is a normal value and indicates that CTRI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CTRI (1.72) is better than 90.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.72
Quick Ratio 1.72
CTRI Yearly Current Assets VS Current LiabilitesCTRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 96.24% over the past year.
The Revenue has decreased by -9.04% in the past year.
The Revenue has been growing slightly by 6.90% on average over the past years.
EPS 1Y (TTM)96.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5%
Revenue 1Y (TTM)-9.04%
Revenue growth 3Y6.9%
Revenue growth 5YN/A
Sales Q2Q%7.73%

3.2 Future

The Earnings Per Share is expected to grow by 58.25% on average over the next years. This is a very strong growth
CTRI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.75% yearly.
EPS Next Y118.09%
EPS Next 2Y79.47%
EPS Next 3Y58.25%
EPS Next 5YN/A
Revenue Next Year6.69%
Revenue Next 2Y6.03%
Revenue Next 3Y5.75%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CTRI Yearly Revenue VS EstimatesCTRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CTRI Yearly EPS VS EstimatesCTRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 60.76, the valuation of CTRI can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of CTRI is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.91, CTRI is valued quite expensively.
The Price/Forward Earnings ratio is 22.12, which indicates a rather expensive current valuation of CTRI.
Based on the Price/Forward Earnings ratio, CTRI is valued a bit cheaper than 77.36% of the companies in the same industry.
CTRI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.30, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 60.76
Fwd PE 22.12
CTRI Price Earnings VS Forward Price EarningsCTRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CTRI is valued cheaply inside the industry as 86.79% of the companies are valued more expensively.
86.79% of the companies in the same industry are more expensive than CTRI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.84
EV/EBITDA 10.39
CTRI Per share dataCTRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CTRI's earnings are expected to grow with 58.25% in the coming years.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y79.47%
EPS Next 3Y58.25%

0

5. Dividend

5.1 Amount

CTRI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CENTURI HOLDINGS INC

NYSE:CTRI (10/9/2025, 3:14:09 PM)

20.66

+0.33 (+1.62%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-04 2025-11-04
Inst Owners56.39%
Inst Owner Change0%
Ins Owners0.35%
Ins Owner Change-19068%
Market Cap1.83B
Analysts75.38
Price Target24.38 (18.01%)
Short Float %3.54%
Short Ratio1.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.02%
Min EPS beat(2)-22.01%
Max EPS beat(2)19.97%
EPS beat(4)1
Avg EPS beat(4)-21.69%
Min EPS beat(4)-80.47%
Max EPS beat(4)19.97%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.31%
Min Revenue beat(2)-0.09%
Max Revenue beat(2)0.7%
Revenue beat(4)2
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-7.13%
Max Revenue beat(4)4.44%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.14%
EPS NQ rev (1m)2.03%
EPS NQ rev (3m)-0.05%
EPS NY rev (1m)2.48%
EPS NY rev (3m)-4.26%
Revenue NQ rev (1m)-0.3%
Revenue NQ rev (3m)1.33%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)1.07%
Valuation
Industry RankSector Rank
PE 60.76
Fwd PE 22.12
P/S 0.68
P/FCF 13.84
P/OCF 8.19
P/B 3.23
P/tB N/A
EV/EBITDA 10.39
EPS(TTM)0.34
EY1.65%
EPS(NY)0.93
Fwd EY4.52%
FCF(TTM)1.49
FCFY7.22%
OCF(TTM)2.52
OCFY12.21%
SpS30.58
BVpS6.4
TBVpS-1.52
PEG (NY)0.51
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.15%
ROE -0.57%
ROCE 5.5%
ROIC 4.34%
ROICexc 4.42%
ROICexgc 7.52%
OM 3.5%
PM (TTM) N/A
GM 8.67%
FCFM 4.88%
ROA(3y)-5.23%
ROA(5y)N/A
ROE(3y)-42.36%
ROE(5y)N/A
ROIC(3y)4.36%
ROIC(5y)N/A
ROICexc(3y)4.47%
ROICexc(5y)N/A
ROICexgc(3y)8.1%
ROICexgc(5y)N/A
ROCE(3y)5.52%
ROCE(5y)N/A
ROICexcg growth 3Y-0.39%
ROICexcg growth 5YN/A
ROICexc growth 3Y9.2%
ROICexc growth 5YN/A
OM growth 3Y-6.01%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.56%
GM growth 5YN/A
F-Score5
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF 7.09
Debt/EBITDA 3.46
Cap/Depr 55.05%
Cap/Sales 3.37%
Interest Coverage 250
Cash Conversion 85.71%
Profit Quality N/A
Current Ratio 1.72
Quick Ratio 1.72
Altman-Z 2.19
F-Score5
WACC11.61%
ROIC/WACC0.37
Cap/Depr(3y)68.49%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.05%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5%
EPS Next Y118.09%
EPS Next 2Y79.47%
EPS Next 3Y58.25%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.04%
Revenue growth 3Y6.9%
Revenue growth 5YN/A
Sales Q2Q%7.73%
Revenue Next Year6.69%
Revenue Next 2Y6.03%
Revenue Next 3Y5.75%
Revenue Next 5YN/A
EBIT growth 1Y-36.39%
EBIT growth 3Y0.48%
EBIT growth 5YN/A
EBIT Next Year148.91%
EBIT Next 3Y45.28%
EBIT Next 5YN/A
FCF growth 1Y-3.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.51%
OCF growth 3Y13.06%
OCF growth 5YN/A